Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
jnjinnovation.com

JLABS Navigator Now Live

About us
JLABS Navigator
- Explore Companies
- Become a Resident
Events
Locations
- JLABS
- Affiliate Sites
- JPODS
  - JPOD @ Philadelphia
  - JPOD @ Boston
- Where we are
  - JLABS Locations
Quickfire Challenges
Media

Search JLABS...

Apply

Apply

English
中文

News

Main tabs

All News
Press releases
JLABS In The media
Company news
Blog
Videos

visually-hidden

Operator

Company

And

Article view
List view

Refine by

Refine by

Type

Other news

Period

2018

Jan

Company

Topics

Categories

Locations & regions

JLABS @ Toronto

Focus area

Clear filters

Why weed tech is missing from CES 2018, even as the budding industry booms

By JLABS

Read full story

Sidebar

Currently trending

Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator
NERv Medical, PATH EX, and Solenic Medical Named Awardees in JLABS @ TMC Breakthrough Medical Technologies QuickFire Challenge
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Johnson & Johnson Innovation Announces Winner of its Advancing the Safe Use of Healthcare Products QuickFire Challenge
Announcing the Breakthrough Medical Technologies QuickFire Challenge
Johnson & Johnson Innovation Announces Winners of the Victorian QuickFire Challenge in Collaboration with Victorian Government
J&J to launch JLABS incubator in Toronto
Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.
Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator, SDI‐118, in development for the treatment of cognitive impairment.
Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Blog posts

Elena

Introducing Elena Fernandez-Kleinlein, new interim head for JLABS in Europe!

Read more

Trending videos

JLABS @ BE Resident Testimonials

JLABS on Twitter

About JLABS
Solutions
Locations
Events
Contact Us

© Johnson & Johnson Innovation, LLC 2019. All Rights Reserved.

Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy. This site is published by Johnson & Johnson Innovation LLC which is solely responsible for its contents. This site is intended for global audiences. Capitalized product names are trademarks of the Johnson & Johnson Family of Companies or its affiliates.

Apply for a new home!

Become a resident